A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

International shows are taking over Netflix and here are three series to add to your watch list - you won't want to miss them ...

This follows the final approval from the US FDA for its abbreviated new drug application (ANDA). Shares of Lupin Ltd ended at ...

Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open Agriculture. Its share price ran on sales of its lupin ...

Lupin 's Omar Sy has been cast in a new Netflix offshoot of a popular action franchise. The star will lead a "high-octane" ...

The Au Pair is about to air on Channel 5 and it follows a bespoke dressmaker who hires an au pair named Sandrine. While it ...

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation ...

From 2019 to today, a variety of delightful new shōnen anime like, Demon Slayer, have hit the airwaves to carry on the torch ...

Here’s how it works. The hit Netflix thriller series Lupin will potentially be returning – but perhaps not in the way fans might have been expecting. The French crime drama became one of ...